Lv3
382 积分 2024-03-06 加入
Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study
17小时前
待确认
Cost-Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
18天前
已完结
A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable advanced pancreatic cancer treated with first-line gemcitabine plus nab-paclitaxel therapy
18天前
已完结
Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial
1个月前
已完结
Comparative effectiveness of five Chinese patent medicines for non-alcoholic fatty liver disease: A systematic review and Bayesian network meta-analysis
2个月前
已完结
Nab -Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer
2个月前
已完结
Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group
2个月前
已完结
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial
2个月前
已完结
Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198)
2个月前
已完结
The efficacy of coaxial percutaneous iodine-125 seed implantation combined with arterial infusion chemotherapy for advanced pancreatic cancer: a randomized clinical trial
2个月前
已完结
p‐ and n‐Type Bipolar Redox‐Active Radical Polymer: Toward Totally Organic Polymer‐Based Rechargeable Devices with Variable Configuration
皖公网安备34019202002308
